Trials / Unknown
UnknownNCT00845403
Antigen-specific Immune Response to Hepatitis B Virus in Utero
Antigen-specific Immune Response to Hepatitis B Virus and Influenza A (H1N1 Strain) in Utero
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- National University Hospital, Singapore · Academic / Other
- Sex
- Female
- Age
- 21 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study aims to gain an understanding of the key components of the immune response to hepatitis B present in cord blood of HBV infected mothers.
Detailed description
Despite the development of an effective preventive HBV vaccine, the spread of HBV virus continue, particularly in Asia, where the majority of HBV infection is acquired at birth by vertical transmission from mother to baby. HBV vertical transmission has been hypothesized to cause immune tolerance to HBV and thus promoting the subsequent HBV chronicity. Such hypothesis has never been tested and nothing is known about HBV-specific adaptive immune response occurring before birth in baby born form HBV chronically infected mothers. This study aims to gain an understanding of the key components of the immune response to hepatitis B present in cord blood of HBV infected mothers. The characterization of the HBV immune response in utero will provide informations about the cause of HBV chronicity in Asian patients in the management of baby born from HBsAg+ mothers.
Conditions
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2009-02-18
- Last updated
- 2014-01-13
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT00845403. Inclusion in this directory is not an endorsement.